NCT03279692 2026-01-29Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade MeningiomaMassachusetts General HospitalPhase 2 Active not recruiting26 enrolled 14 charts
NCT04659811 2025-04-17Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent MeningiomaUniversity of California, San FranciscoPhase 2 Recruiting37 enrolled